Your browser doesn't support javascript.
loading
Initiation of any tobacco and five tobacco products across 3 years among youth, young adults and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).
Stanton, Cassandra A; Sharma, Eva; Seaman, Elizabeth L; Kasza, Karin A; Edwards, Kathryn C; Halenar, Michael J; Taylor, Kristie A; Day, Hannah; Anic, Gabriella; Hull, Lynn C; Bansal-Travers, Maansi; Limpert, Jean; Gardner, Lisa D; Hammad, Hoda T; Borek, Nicolette; Kimmel, Heather L; Compton, Wilson M; Hyland, Andrew.
Afiliación
  • Stanton CA; Behavioral Health and Health Policy Practice, Westat, Rockville, MD, United States cassandrastanton@westat.com.
  • Sharma E; Department of Oncology, Georgetown University Medical Center, Washington, DC, United States.
  • Seaman EL; Behavioral Health and Health Policy Practice, Westat, Rockville, MD, United States.
  • Kasza KA; Behavioral Health and Health Policy Practice, Westat, Rockville, MD, United States.
  • Edwards KC; Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
  • Halenar MJ; Behavioral Health and Health Policy Practice, Westat, Rockville, MD, United States.
  • Taylor KA; Behavioral Health and Health Policy Practice, Westat, Rockville, MD, United States.
  • Day H; Behavioral Health and Health Policy Practice, Westat, Rockville, MD, United States.
  • Anic G; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, United States.
  • Hull LC; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, United States.
  • Bansal-Travers M; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, United States.
  • Limpert J; Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
  • Gardner LD; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, United States.
  • Hammad HT; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, United States.
  • Borek N; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, United States.
  • Kimmel HL; Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, United States.
  • Compton WM; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, United States.
  • Hyland A; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, United States.
Tob Control ; 29(Suppl 3): s178-s190, 2020 05.
Article en En | MEDLINE | ID: mdl-32321852
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Productos de Tabaco / Uso de Tabaco / Sistemas Electrónicos de Liberación de Nicotina / Vapeo Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies Límite: Adolescent / Adult / Child / Humans País/Región como asunto: America do norte Idioma: En Revista: Tob Control Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Productos de Tabaco / Uso de Tabaco / Sistemas Electrónicos de Liberación de Nicotina / Vapeo Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies Límite: Adolescent / Adult / Child / Humans País/Región como asunto: America do norte Idioma: En Revista: Tob Control Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos